• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search

column
Advances in drug development based on immunoregulation
XU Yungen
2024, 55(1): 1-4. DOI: 10.11665/j.issn.1000-5048.2024022601
Abstract PDF
New strategies for targeting PD-1/PD-L1: degraders, bifunctional molecules and covalent inhibitors
WANG Zhijie, LIAO Xiaotong, GUO Xia, CHEN Jianjun
2024, 55(1): 5-14. DOI: 10.11665/j.issn.1000-5048.2023112702
Abstract PDF
Research progress of cGAS-STING signaling pathway modulators in immunotherapy
LOU Fangning, ZHENG Mingyue, CHEN Kaixian, ZHANG Sulin
2024, 55(1): 15-25. DOI: 10.11665/j.issn.1000-5048.2023112402
Abstract PDF
Research progress on the antitumor effects of platinum-based chemo-immunotherapies
CHEN Feihong, ZHAO Deming, GOU Shaohua
2024, 55(1): 26-35. DOI: 10.11665/j.issn.1000-5048.2023120201
Abstract PDF
Research progress of drugs for cancer immunotherapy based on CCL2/CCR2 signaling axis
CUI Zhenzhen, ZHAO Yifan, SUN Yu, Meng Jiayi, KANG Di, HU Lihong
2024, 55(1): 36-44. DOI: 10.11665/j.issn.1000-5048.2023112904
Abstract PDF
Research progress on targeted protein S-palmitoylation modification in T cell immunotherapy
SUN Liting, ZHANG Weiguo, TONG Yue
2024, 55(1): 45-52. DOI: 10.11665/j.issn.1000-5048.2023112903
Abstract PDF
Progress of gene-mediated precision immunotherapy in the treatment of acute myeloid leukemia
ZHAO Pengbo, ZHU Ying, YIN Lifang, XIN Xiaofei
2024, 55(1): 53-62. DOI: 10.11665/j.issn.1000-5048.2023112703
Abstract PDF
Research progress of Bruton's tyrosine kinase (BTK) inhibitors in the treatment of inflammatory and immune-mediated diseases
REN Weijie, CEN Lifang, ZOU Yi
2024, 55(1): 63-72. DOI: 10.11665/j.issn.1000-5048.2023121103
Abstract PDF
Design, synthesis and biological study of BTK/JAK3 dual-target inhibitors
CEN Lifang, CHENG Ming, REN Weijie, YE Liu, WANG Luhua, GUO Weibo, ZHANG Qiang, XU Yungen
2024, 55(1): 73-86. DOI: 10.11665/j.issn.1000-5048.2024010201
Abstract PDF
Progress in discovery of RORγt inverse agonists for the treatment of autoimmune diseases
LU Lixue, WANG Yonghui
2024, 55(1): 87-102. DOI: 10.11665/j.issn.1000-5048.2023121303
Abstract PDF
Research progress on mesenchymal stem cell products and their exosomes in the treatment of inflammatory bowel disease
YANG Jingwen, CHEN Qian, SHAN Yunlong, LIU Jiali, WEI Ning, WANG Jing, WANG Guangji, ZHOU Fang
2024, 55(1): 103-114. DOI: 10.11665/j.issn.1000-5048.2023113001
Abstract PDF
Progress and prospect of global vaccine research and development
MA Lei, YANG Zhaoqing, WANG Youchun
2024, 55(1): 115-126. DOI: 10.11665/j.issn.1000-5048.2023121601
Abstract PDF
Exploration and practice of mRNA technology in vaccine development
LIU Jian
2024, 55(1): 127-136. DOI: 10.11665/j.issn.1000-5048.2023122401
Abstract PDF
A comparative analysis of vaccine immunity induced by heterologous booster with Ad5-nCoV via different routes of administration
MA Wenxuan, HAN Yuhong, LIN Ang, ZHAO Weijun
2024, 55(1): 137-146. DOI: 10.11665/j.issn.1000-5048.2024011701
Abstract PDF

Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

Total visits：407065